Global Blood Fund (uk)
Other human health activities
Global Blood Fund (uk) contacts: address, phone, fax, email, website, shedule
Address: Moorgate House 5-8 Dysart Street EC2A 2BX London
Phone: +44-141 3179412
Fax: +44-141 3179412
Email: n\a
Website: n\a
Shedule:
Incorrect data or we want add more details informations for "Global Blood Fund (uk)"? - send email to us!
Registration data Global Blood Fund (uk)
Register date: 2012-05-21
Register number: 08076380
Type of company: Pri/lbg/nsc (private, Limited By Guarantee, No Share Capital, Use Of 'limited' Exemption)
Get full report form global database UK for Global Blood Fund (uk)Owner, director, manager of Global Blood Fund (uk)
Randall Stark Director. Address: 1001 N Lincoln Blvd, Oklahoma City, Oklahoma, 73104, United States. DoB: October 1961, Usa
Mark Patterson Director. Address: 1001 N Lincoln Blvd, Oklahoma City, Oklahoma, 73104, United States. DoB: September 1956, Usa
Dr John Armitage Director. Address: 1001 N Lincoln Blvd, Oklahoma City, Oklahoma, 73104, United States. DoB: July 1964, Usa
Jobs in Global Blood Fund (uk) vacancies. Career and practice on Global Blood Fund (uk). Working and traineeship
Sorry, now on Global Blood Fund (uk) all vacancies is closed.
Responds for Global Blood Fund (uk) on FaceBook
Read more comments for Global Blood Fund (uk). Leave a respond Global Blood Fund (uk) in social networks. Global Blood Fund (uk) on Facebook and Google+, LinkedIn, MySpaceAddress Global Blood Fund (uk) on google map
Other similar UK companies as Global Blood Fund (uk): Uton Limited | Bml Services Ltd | Binzo Ltd | Fida Holdings Limited | E A Mussen Enterprises Ltd
The business is situated in London under the following Company Registration No.: 08076380. This firm was established in 2012. The main office of the company is located at Moorgate House 5-8 Dysart Street. The post code for this address is EC2A 2BX. The firm SIC and NACE codes are 86900 , that means Other human health activities. 2014-05-31 is the last time the accounts were filed.
The following company owes its success and unending development to exactly three directors, who are Randall Stark, Mark Patterson and Dr John Armitage, who have been guiding the company since May 21, 2012.